AQR CAPITAL MANAGEMENT LLC
Position in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 1167557
Greenwich, CT
Position in CPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,653,969
-$1,433,242 QoQ
Shares Held
228,351
-24.8% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. CPRX ranks #52 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in CPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,653,969 | 228,351 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,087,211 | 303,651 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $6,639,923 | 337,052 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $8,645,754 | 398,422 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $10,803,616 | 445,510 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $9,955,218 | 477,011 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $9,131,916 | 459,352 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,565,097 | 488,386 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $4,161,375 | 261,065 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $5,762,484 | 342,801 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,573,792 | 476,800 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,641,839 | 642,994 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,380,833 | 264,224 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,248,798 | 228,430 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,140,095 | 400,631 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,417,662 | 487,541 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,428,346 | 413,552 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,965,754 | 438,073 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,519,180 | 475,317 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,864,138 | 324,198 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,336,040 | 723,653 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,318,059 | 993,431 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,523,110 | 849,532 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $4,182,227 | 905,244 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $4,667,928 | 1,212,449 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||